Abstract

Introduction Reactive oxygen species (ROS) and free radicals are byproducts of oxidative metabolism that cause cellular damage and are implicated in the pathogenesis of age-related diseases. Mitochondria are the main cellular sites of ROS production. Recent studies reported a positive correlation between mitochondria dysfunction and age-associated disk cellular senescence and apoptosis. Hence, we hypothesize that reducing mitochondria-generated ROS would slow the onset of age-related intervertebral disk degeneration (IDD). We tested this hypothesis by chronically treating the Errc1-/D mouse model of accelerated aging with XJB-5-131, a mitochondria-targeted free radical scavenger previously demonstrated to be therapeutic in rodent models of hemorrhagic shock and sepsis. Materials and Methods Pairs of 5-week-old siblings of Ercc1-/▵ mice were treated with XJB-5-131 or oil carrier control (intraperitoneal injections, 2 mg/Kg, 3×/week, 15 weeks). Total proteoglycan content (safranin-O histology, DMMB assay) and synthesis (35S-sulfate incorporation) were measured. Transmission electron microscopy (TEM) was performed to assess disk mitochondria number and morphology in Ercc1-/▵ mice and wild-type littermates. Results TEM showed greater mitochondrial death in discs of Ercc1-/▵ mice compared to their wild-type littermates. Compared to oil-treated Ercc1-/▵ controls, disks from XJB-5-131 treated Ercc1-/▵mice showed greater (1.3×) proteoglycan matrix content and higher (1.9×) rate of proteoglycan synthesis. Conclusion Errc1-/Dmouse model of a human progeria had previously established as an accurate model of spine aging. Treatment of Errc1-/Dmice with a mitochondria-targeted ROS scavenger decreased disk proteoglycan loss. This result is consistent with our in vitro studies which showed XJB-5-131 is able to rescue reduced proteoglycan synthesis mediated by oxidative stress in human disk cells grown at high oxygen (20 vs. 5% oxygen). The findings in this study suggest that oxidative damage originating from mitochondria dysfunction plays an important role in disk health. The mitochondrial-targeted ROS free radical scavenger XJB-5-131 is potentially therapeutic in delaying the onset of age-related IDD. I confirm having declared any potential conflict of interest for all authors listed on this abstract Yes Disclosure of Interest None declared

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call